Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Applied Therapeutics Inc APLT

Healthcare Biotechnology
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company’s lead drug candidate, govorestat, is a novel central nervous system penetrant Aldose Reductase Inhibitor (ARI) for the treatment of central nervous system (CNS) rare... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:APLT)

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer

GlobeNewswire 5 days ago

Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024

GlobeNewswire April 4, 2024

Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia

GlobeNewswire March 28, 2024

Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results

GlobeNewswire March 6, 2024

Applied Therapeutics Announces $100 Million Private Placement

GlobeNewswire February 28, 2024

Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia

GlobeNewswire February 28, 2024

Applied Therapeutics Announces Positive Results from 12-month Interim Analysis of Govorestat (AT-007) in the Ongoing INSPIRE Phase 3 Trial in Sorbitol Dehydrogenase (SORD) Deficiency

GlobeNewswire February 15, 2024

Applied Therapeutics Announces Topline Results from the ARISE-HF Phase 3 Study of AT-001 in Diabetic Cardiomyopathy

GlobeNewswire January 4, 2024

Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic Galactosemia

GlobeNewswire January 3, 2024
View More News ››

Opinion & Analysis (NDAQ:APLT)

Applied Therapeutics Investors Like the ACTION in Phase 2 Galactosemia Study

Streetwise Reports January 9, 2020
View More Opinion ››

Bullboard Posts (NDAQ:APLT)

Applied Therapeutics Inc. (NASDAQ: APLT) Records 52-Week Hig

NEWS: $APLT Applied Therapeutics Inc. (NASDAQ: APLT) Records 52-Week High Wednesday MorningShares of Applied Therapeutics, Inc. (NASDAQ:...
whytestocks - February 28, 2024

Applied Therapeutics Announces FDA Acceptance and Priority R

BREAKING NEWS: $APLT Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the...
whytestocks - February 28, 2024

Applied Therapeutics Announces $100 Million Private Placemen

Breaking News: $APLT Applied Therapeutics Announces $100 Million Private PlacementFinancing includes significant participation from a...
whytestocks - February 28, 2024

Applied Therapeutics Announces MAA Validation and NDA Submis

Just In: $APLT Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic...
whytestocks - January 3, 2024
View more Bullboard ››

TAG Oil Ltd.

TAG Oil Ltd.

TAG Oil Ltd. is a Canadian-based international oil and gas exploration company. The Company is focused on oil and gas ...
View More »